Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Giovanni Apolone"'
Autor:
Filippo de Braud, Loris De Cecco, Debora Fumagalli, Elda Tagliabue, Valter Torri, Jens Huober, Saverio Cinieri, Maria Grazia Daidone, Miguel Izquierdo, Giovanni Apolone, Serena Di Cosimo, Martine Piccart, Lorena de la Peña, Sara Pizzamiglio, Stefania Gori, José Baselga, Nadia Harbeck, Lajos Putzai, Tiziana Triulzi, Evandro de Azambuja, Paolo Verderio
Publikováno v:
European journal of cancer, 118
Background: Dual HER2-inhibition combined with neoadjuvant chemotherapy allows increased pathological complete response (pCR) rate. However, with the addition of new agents, there is a growing need to select patients to minimise overtreatment. Herein
Autor:
Samantha Pesce, Luca Lalli, Giovanni Fucà, Angela Maria Rizzo, Arta Ajazi, Giancarlo Pruneri, Paola Squarcina, Viviana Vallacchi, Licia Rivoltini, Marco Foiani, Valeria Cancila, Salvatore Cortellino, Cristina Ferraris, Davide Bedognetti, Federica Zanardi, Alessandra Raimondi, Claudio Vernieri, Gianmaria Frigè, Andrea Vingiani, Darawan Rinchai, Francesca Ligorio, Giovanni Apolone, Valter D. Longo, Valter Torri, Giulia Bianchi, Saverio Minucci, Marina Chiara Garassino, Claudia Chiodoni, Filippo de Braud, Raghvendra Mall, Paola Frati, Giuseppe Capri, Fabio Iannelli, Antonino Belfiore, Agata Cova, Mario P. Colombo, Secondo Folli, Veronica Huber, Paola Antonia Corsetto
Publikováno v:
Cancer discovery. 12(1)
In tumor-bearing mice, cyclic fasting or fasting-mimicking diets (FMD) enhance the activity of antineoplastic treatments by modulating systemic metabolism and boosting antitumor immunity. Here we conducted a clinical trial to investigate the safety a
Autor:
Alessandro Gulino, Biagio Paolini, Anna Moretti, Gianfranco Scaperrotta, Serena Di Cosimo, Luigi Mariani, Mario P. Colombo, Marina Elena Cazzaniga, Giulia Bianchi, Giovanni Apolone, Massimo Di Nicola, Flavio Crippa, Claudio Tripodo, Valter Torri, Filippo de Braud, Maria De Santis, Nicla La Verde, S. Folli, Daniele Generali
Publikováno v:
PLoS ONE, Vol 14, Iss 8, p e0220644 (2019)
PLoS ONE
PLoS ONE
BackgroundEribulin mesylate (E) is indicated for metastatic breast cancer patients previously treated with anthracycline and taxane. We argued that E could also benefit patients eligible for neoadjuvant chemotherapy.MethodsPatients with primary tripl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d35afef2962d02f3b60bf2918efc0050
http://hdl.handle.net/10447/395016
http://hdl.handle.net/10447/395016
Autor:
Giovanni Apolone, A. Zaniboni, Gianfranco Pavia, R. Labianca, Bruno Andreoni, N. Pinna, Frank E. Johnson, Eva Negri, Gianfranco Pancera, Gerardo Rosati, Sandro Barni, Pietro Sozzi, Roldano Fossati, Valter Torri, G. Solina, Paola Mosconi, G. Ambrosini, F. Gaion, G. Corradini, G. Martignoni, Giovanna Luchena, Sandro Pignata, Bruno Daniele, Marta Monteforte, M. Duro, Giovanni Oliverio
Publikováno v:
Annals of Oncology. 27:274-280
Background Colorectal cancer is the third most common and the third most lethal cancer in both men and women in developed countries. About 75% of cases are first diagnosed when the disease is classified as localized or regional, undergo potentially c
Autor:
Giovanni Apolone, Maria Grazia Daidone, Paolo Verderio, Marilena V. Iorio, Paola Tiberio, Florentine Hilbers, Filippo de Braud, Sara Pizzamiglio, Serena Di Cosimo, Jens Huober, Evandro de Azambuja, Martine Piccart, Lorena de la Peña, José Baselga, Valentina Appierto, Miguel Izquierdo
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 25(13)
Purpose: To investigate the potential of circulating-miRNAs (ct-miRNA) as noninvasive biomarkers to predict the efficacy of single/dual HER2-targeted therapy in the NeoALTTO study. Experimental Design: Patients with plasma samples at baseline (T0) an
Autor:
Giovanni Corrao, Gustavo Galmozzi, Elena Bertocchi, Vincenzo Mazzaferro, Ugo Pastorino, Martin Langer, Giovanna Pomponi, Giovanni Leuzzi, Anna Cantarutti, Giovanni Apolone, Carlotta Galeone
Background: Accurate measurement of outcomes is essential to monitor the effectiveness of public health policies. In Italy, the Ministry of Health has chosen 30-day mortality after major surgical or medical procedures as the main outcome measure, poo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d317c2ca62d4b87d50a02599045c60f
http://hdl.handle.net/10281/186783
http://hdl.handle.net/10281/186783
Autor:
Walter Villani, Maria Teresa Greco, Giovanni Apolone, Silvia Deandrea, Oscar Corli, Mauro Montanari
Publikováno v:
Pain Medicine. 13:897-907
Objective. This analysis, carried out in the context of a wider observational prospective study, tried to explore whether four World Health Organization/step-III opioids (morphine, oxycodone, fentanyl, and buprenorphine) had different effectiveness w
Autor:
Cinzia Brunelli, Nina Aass, Mauro Montanari, Pål Klepstad, Giovanni Apolone, Augusto Caraceni, Oscar Corli, Stein Kaasa, Anne Kari Knudsen
Publikováno v:
Pain. 153:696-703
The overall aim of the present study was to further develop an evidence-based platform for the content of an international cancer pain classification system. Data from a multicentre, observational longitudinal study of cancer patients were analysed.
Autor:
Massimo Allegri, Giovanni Apolone, Vittorina Zagonel, Raffaele Addeo, Silvia Deandrea, Angelo Delmonte, Maria Teresa Greco, GAETANO FACCHINI
Publikováno v:
The Clinical Journal of Pain. 27:9-18
Breakthrough cancer pain (BTcP) is a frequent event in cancer patients, with a prevalence from 19% to 95%. The reasons for such variability are explained by several factors, including different definitions across studies. In the framework of a wider
Autor:
Giovanni Apolone, E. Negri, Silvia Deandrea, Maria Teresa Greco, A. Caraceni, Mauro Montanari, Oscar Corli
Publikováno v:
British Journal of Cancer
Most patients with advanced or metastatic cancer experience pain and despite several guidelines, undertreatment is well documented. A multicenter, open-label, prospective, non-randomised study was launched in Italy in 2006 to evaluate the epidemiolog